GlassScriptPhysician profile
Matthew Morris
NPI 1811494446
$9,346.66
in general payments reported to CMS, 2019-2025
17 companies · $4,210 in 2025
The $4,210 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,018 · 2024: $4,119 · 2025: $4,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,588 · Food and Beverage: $2,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,587.97 |
| Food and Beverage | $2,758.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $3,523.08 | 2024 | Other - Miscellaneous |
| Spineart USA INC | $2,658.24 | 2025 | |
| Medtronic, INC. | $1,018.97 | 2023-2025 | Cd Horizon Spinal System, Inceptiv, Kyphon Express II Kyphopak Tray |
| Medacta USA, INC. | $699.54 | 2024-2025 | Myspine |
| Cerapedics INC. | $402.49 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Trackx Technology, INC. | $172.56 | 2024 | |
| Spineology INC. | $170.41 | 2025 | |
| Bioventus LLC | $138.97 | 2023-2024 | Bonescalpel, Bonescalpel & Sonicone (O.R.) |
| Globus Medical, INC. | $136.41 | 2025 | X-Core |
| Kyocera Medical Technologies, INC. | $125.24 | 2025 | |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
| Providence Medical Technology, INC. | $70.65 | 2023-2025 | |
| Stryker Corporation | $58.42 | 2023 | Mako |
| Smith+Nephew, INC. | $21.02 | 2025 | Pico 14 |
| Cook Medical LLC | $17.92 | 2023 | Zilver Ptx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $17.05 | 2024 | Spinal-Stim |
| Solventum Corporation | $14.69 | 2025 | Promogran Prisma, Activ.A.C., 3m Cavilon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.